Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Janssen, Y. Schymura, A. Wietelmann, J. P. Stasch, H. Luitel, N. Weissmann, H. A. Ghofrani, F. Grimminger, T. Braun, W. Seeger, R. T. Schermuly (Bad Nauheim, Giessen, Wuppertal, Germany). Effects of BAY 41-8543 and sildenafil on right heart structure and function in pulmonary artery banded mice. Eur Respir J 2011; 38: Suppl. 55, 2290

Member's Comments

No comment yet.

Related content which might interest you: Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension Source: International Congress 2018 – On the right path: understanding and improving the function of an overloaded right heart ventricle Year: 2018 REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH) Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)> Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Effects of a soluble guanylate cyclase stimulator, BAY 41-8543, upon right ventricular function in experimental pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Regional right ventricular function versus hemodynamics in pulmonary arterial hypertension: an ultrasonic strain and strain rate study Source: Eur Respir J 2003; 22: Suppl. 45, 464s Year: 2003 Pulmonary artery pressure (PAP) reduction by systemic and inhaled nitroglycerin (NTG) in an isolated rabbit lung model of pulmonary hypertension (PH) Source: Eur Respir J 2003; 22: Suppl. 45, 270s Year: 2003 Acute effect of sildenafil (PDE-5) on cardiopulmonary interactions in patients with pulmonary arterial hypertension (PAH) secondary to pulmonary fibrosis Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension (PAH) associated with congenital heart defects (CHD) Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 The association between resting and mild-to-moderate exercise pulmonary artery pressure Source: Eur Respir J 2012; 39: 313-318 Year: 2012 Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Pulmonary hemodynamics and remodeling of the right heart in patients with COPD, depending on the risk group. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Right ventricular (RV) morphometric and ventriculo-vascular (VV) coupling patterns in patients with advanced pulmonary arterial hypertension (PAH) undergoing parenteral treprostinil therapy Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017